EMAIL THIS PAGE TO A FRIEND

Scientific reports

Systemic Administration of siRNA via cRGD-containing Peptide.


PMID 26300278

Abstract

Although small interfering RNAs (siRNAs) have been demonstrated to specifically silence their target genes in disease models and clinical trials, in vivo siRNA delivery is still the technical bottleneck that limits their use in therapeutic applications. In this study, a bifunctional peptide named RGD10-10R was designed and tested for its ability to deliver siRNA in vitro and in vivo. Because of their electrostatic interactions with polyarginine (10R), negatively charged siRNAs were readily complexed with RGD10-10R peptides, forming spherical RGD10-10R/siRNA nanoparticles. In addition to enhancing their serum stability by preventing RNase from attacking siRNA through steric hindrance, peptide binding facilitated siRNA transfection into MDA-MB-231 cells, as demonstrated by FACS and confocal microscopy assays and by the repressed expression of target genes. When RGD10 peptide, a receptor competitor of RGD10-10R, was added to the transfection system, the cellular internalization of RGD10-10R/siRNA was significantly compromised, suggesting a mechanism of ligand/receptor interaction. Tissue distribution assays indicated that the peptide/siRNA complex preferentially accumulated in the liver and in several exocrine/endocrine glands. Furthermore, tumor-targeted delivery of siRNA was also demonstrated by in vivo imaging and cryosection assays. In summary, RGD10-10R might constitute a novel siRNA delivery tool that could potentially be applied in tumor treatment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW22763 Anti-GAPDH antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB3500247
Anti-GAPDH antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1405848
Anti-GAPDH antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2701826
Anti-gapdh antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701825
Anti-gapdh antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2103104
Anti-GAPDH antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB4300645
Anti-GAPDH antibody produced in rabbit, affinity isolated antibody
HPA040067
Anti-GAPDH antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2500450
Anti-GAPDH, C-Terminal antibody produced in goat, affinity isolated antibody, buffered aqueous solution
PLA0302
Goat anti-GAPDH Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
CDS019936
Isoflurane, AldrichCPR
C3H2ClF5O
WH0002597M1
Monoclonal Anti-GAPDH antibody produced in mouse, clone 3C2, purified immunoglobulin, buffered aqueous solution
SAB1403850
Monoclonal Anti-GAPDH, (C-terminal) antibody produced in mouse, clone 1G5, purified immunoglobulin, buffered aqueous solution
PLA0125
Rabbit anti-GAPDH Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.